Ipilimumab 200mg/40ml solution for infusion vials
NHS hospitals in England used £57,923,625 of indicative cost of Ipilimumab 200mg/40ml solution for infusion vials in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 34.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ipilimumab 200mg/40ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ipilimumab 200mg/40ml solution for infusion vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Manchester University Nhs Ft | £9,075,000 |
| Univ Hpl B/Ham Nhs Foundation Trust | £3,750,000 |
| Southend Univ Hosp Nhs Foundation Trust | £1,920,000 |
| The Christie Nhs Foundation Trust | £1,908,750 |
| The Clatterbridge Cancer Centre Nhs Ft | £1,899,375 |
| Sheffield Teaching Hospitals Nhs Trust | £1,815,000 |
| Leeds Teaching Hpls Nhs Trust | £1,695,000 |
| Royal Surrey County Hosp Nhs Found Trust | £1,636,875 |
| Portsmouth Hospitals Nhs Trust | £1,548,000 |
| The Royal Marsden Nhs Foundation Trust | £1,515,000 |
The primary-care picture
Ipilimumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ipilimumab medicine page.